Iambic Therapeutics, Inc.
IAM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001997038
In the last 90 days, Iambic Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Iambic Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $11.5M in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$11.5M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Iambic Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Petrocheilos George C | 10% Owner | 742,546Indirect | Oct 19, 2026 | 1 |
| Catalio Nexus Fund III, LP | 10% Owner | 742,546Indirect | Oct 19, 2026 | 1 |
| Catalio Capital Management, LP | 10% Owner | 742,546Indirect | Oct 19, 2026 | 1 |
| Catalio Access Fund VIII, LLC | 10% Owner | 742,546Indirect | Oct 19, 2026 | 1 |
| Catalio BH SPV, LLC | 10% Owner | 742,546Indirect | Oct 19, 2026 | 1 |
| Vogelstein R Jacob | Director | 742,546Indirect | Oct 19, 2026 | 2 |
| Secora Michael | CFO & Chief Corp Dev Ofcr | 279,902 | Oct 19, 2026 | 2 |
| Rastetter William H | Director, Other: Chairperson of the Board | 200,920Indirect | Oct 19, 2026 | 2 |
| Rachlin Evan Lockwood | Director | 57,754Indirect | Oct 19, 2026 | 2 |
| Emster Kurt Von | Director | – | Oct 16, 2026 | 1 |
| Tagliaferri Mary | Director | – | Oct 16, 2026 | 1 |
| Sharp Shalini | Director | – | Oct 16, 2026 | 1 |
| Olson Peter A | Chief Scientific Officer | 30,909 | Oct 16, 2026 | 1 |
| Josephson Neil | Chief Medical Officer | 71,459 | Oct 16, 2026 | 1 |
| Manby Frederick R | Chief Technology Officer | 1,862,665 | Oct 16, 2026 | 1 |
| Miller Thomas F. | Chief Executive Officer | 1,410,756 | Oct 16, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 (view filing)7:47 PM ET | Oct 16 | 3 days | Rachlin Evan LockwoodDirector | PPurchase | +718.8K | $16.00 | +$11.5M | +38.4%2.59M after |